Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Fufang Congrong Yizhi Capsules (FCYC) to Cognitive Impairment After Robot-assisted Neurosurgical Management for Intracerebral Hemorrhage(CONPAIR)

NCT06673602 is registered in ClinicalTrials.gov with Qinhuangdao Hospital of Traditional Chinese Medicine as lead sponsor.

NCT NCT06673602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06673602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Fufang Congrong Yizhi Capsules (FCYC) to Cognitive Impairment After Robot-assisted Neurosurgical Management for Intracerebral Hemorrhage(CONPAIR)
Lead sponsor
Qinhuangdao Hospital of Traditional Chinese Medicine
Phase
Phase 4
Overall status
Recruiting
Start date
November 4, 2024
Completion date
June 30, 2026
Enrollment
200 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, intracerebral hemorrhage